| Year |
Citation |
Score |
| 2020 |
Xu Y, Zhang X, Wang N, Pei X, Guo Y, Wang J, Barth S, Yu F, Jin Lee S, He H, Yang VC. Cell-Penetrating Peptide Enhanced Insulin Buccal Absorption. International Journal of Pharmaceutics. 119469. PMID 32470482 DOI: 10.1016/J.Ijpharm.2020.119469 |
0.346 |
|
| 2020 |
Ji X, Xie S, Jiao Y, Zhang X, Sun D, Yang VC, Wang M, He H, Sun L. MT1-MMP activatable fluorogenic probes with enhanced specificity via high-affinity peptide conjugation for tumor imaging. Biomaterials Science. PMID 32186291 DOI: 10.1039/C9Bm02007A |
0.301 |
|
| 2020 |
Liu Q, Zhang L, Ji X, Shin MC, Xie S, Pan B, Yu F, Zhao J, Yang VC. A self-assembly and stimuli-responsive fusion gelonin delivery system for tumor treatment Journal of Industrial and Engineering Chemistry. 89: 409-415. DOI: 10.1016/J.Jiec.2020.06.012 |
0.445 |
|
| 2019 |
Cui H, Zhang B, Ding H, Hu Y, Wang X, Xu L, Jiao X, He H, Wang X, Zeng X, Yang VC. A -Diol/pH Dual-Responsive Upconversion Nanoplatform: Synthesis, Characterization, and Demonstration. Journal of Biomedical Nanotechnology. 15: 487-499. PMID 31165694 DOI: 10.1166/jbn.2019.2700 |
0.303 |
|
| 2018 |
Liu E, Zhang M, Cui H, Gong J, Huang Y, Wang J, Cui Y, Dong W, Sun L, He H, Yang VC. Tat-functionalized Ag-FeO nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery. Acta Pharmaceutica Sinica. B. 8: 956-968. PMID 30505664 DOI: 10.1016/J.Apsb.2018.07.012 |
0.449 |
|
| 2018 |
Ye J, Pei X, Cui H, Yu Z, Lee H, Wang J, Wang X, Sun L, He H, Yang VC. Cellular uptake mechanism and comparative in vitro cytotoxicity studies of monomeric LMWP-siRNA conjugate Journal of Industrial and Engineering Chemistry. 63: 103-111. DOI: 10.1016/J.Jiec.2018.02.005 |
0.381 |
|
| 2017 |
Wang H, Moon C, Shin MC, Wang Y, He H, Yang VC, Huang Y. Heparin-Regulated Prodrug-Type Macromolecular Theranostic Systems for Cancer Therapy. Nanotheranostics. 1: 114-130. PMID 29071181 DOI: 10.7150/ntno.18292 |
0.608 |
|
| 2017 |
Ye J, Liu E, Gong J, Wang J, Huang Y, He H, Yang VC. High-Yield Synthesis of Monomeric LMWP(CPP)-siRNA Covalent Conjugate for Effective Cytosolic Delivery of siRNA. Theranostics. 7: 2495-2508. PMID 28744330 DOI: 10.7150/thno.19863 |
0.304 |
|
| 2017 |
Li R, Pang Z, He H, Lee S, Qin J, Wu J, Pang L, Wang J, Yang VC. Drug depot-anchoring hydrogel: A self-assembling scaffold for localized drug release and enhanced stem cell differentiation. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28694033 DOI: 10.1016/J.Jconrel.2017.07.008 |
0.354 |
|
| 2017 |
Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC. Tandem-Multimeric F3-Gelonin Fusion Toxins for Enhanced Anti-Cancer Activity for Prostate Cancer Treatment. International Journal of Pharmaceutics. PMID 28359823 DOI: 10.1016/J.Ijpharm.2017.03.072 |
0.597 |
|
| 2017 |
Huang Y, Yang VC, Li F, Shin MC, Wang H, Min KA, Zhang M, Chen Y. Improved Protein Toxin Delivery Based on ATTEMPTS Systems. Current Drug Targets. PMID 28260497 DOI: 10.2174/1389450118666170302094758 |
0.418 |
|
| 2017 |
Gao W, Ye G, Duan X, Yang X, Yang VC. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer. International Journal of Nanomedicine. 12: 1047-1064. PMID 28223798 DOI: 10.2147/Ijn.S115215 |
0.391 |
|
| 2017 |
Lee K, David AE, Zhang J, Shin MC, Yang VC. Enhanced accumulation of theranostic nanoparticles in brain tumor by external magnetic field mediated in situ clustering of magnetic nanoparticles Journal of Industrial and Engineering Chemistry. 54: 389-397. DOI: 10.1016/J.Jiec.2017.06.019 |
0.421 |
|
| 2017 |
Zhang P, Ye J, Liu E, Sun L, Zhang J, Lee S, Gong J, He H, Yang VC. Aptamer-coded DNA nanoparticles for targeted doxorubicin delivery using pH-sensitive spacer Frontiers of Chemical Science and Engineering. 11: 529-536. DOI: 10.1007/S11705-017-1645-Z |
0.385 |
|
| 2016 |
Lin T, Zhao P, Jiang Y, Tang Y, Jin H, Pan Z, He H, Yang VC, Huang Y. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy. Acs Nano. 10: 9999-10012. PMID 27934069 DOI: 10.1021/Acsnano.6B04268 |
0.448 |
|
| 2016 |
Ye J, Liu E, Yu Z, Pei X, Chen S, Zhang P, Shin MC, Gong J, He H, Yang VC. CPP-Assisted Intracellular Drug Delivery, What Is Next? International Journal of Molecular Sciences. 17. PMID 27854260 DOI: 10.3390/Ijms17111892 |
0.442 |
|
| 2016 |
Lin T, Liu E, He H, Shin MC, Moon C, Yang VC, Huang Y. Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides. Acta Pharmaceutica Sinica. B. 6: 352-8. PMID 27471676 DOI: 10.1016/J.Apsb.2016.04.001 |
0.589 |
|
| 2016 |
Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC. Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity. Pharmaceutical Research. PMID 27251414 DOI: 10.1007/S11095-016-1959-4 |
0.592 |
|
| 2016 |
Sheng J, He H, Han L, Qin J, Chen S, Ru G, Li R, Yang P, Wang J, Yang VC. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 27178809 DOI: 10.1016/J.Jconrel.2016.05.015 |
0.336 |
|
| 2016 |
Chen S, Liang Q, Xie S, Liu E, Yu Z, Sun L, Shin MC, Lee SJ, He H, Yang VC. Curcumin based combination therapy for anti-breast cancer: from in vitro drug screening to in vivo efficacy evaluation Frontiers of Chemical Science and Engineering. 10: 383-388. DOI: 10.1007/S11705-016-1574-2 |
0.381 |
|
| 2015 |
He H, Sun L, Ye J, Liu E, Chen S, Liang Q, Shin MC, Yang VC. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 26514292 DOI: 10.1016/J.Jconrel.2015.10.040 |
0.445 |
|
| 2015 |
Wang Y, Lin T, Zhang W, Jiang Y, Jin H, He H, Yang VC, Chen Y, Huang Y. A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging. Theranostics. 5: 787-95. PMID 26000052 DOI: 10.7150/Thno.11139 |
0.346 |
|
| 2015 |
Shin MC, Zhang J, Min KA, He H, David AE, Huang Y, Yang VC. PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study. Pharmaceutical Research. 32: 2690-703. PMID 25701313 DOI: 10.1007/S11095-015-1653-Y |
0.305 |
|
| 2015 |
Ye J, Shin MC, Liang Q, He H, Yang VC. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. 205: 58-69. PMID 25483423 DOI: 10.1016/J.Jconrel.2014.12.002 |
0.441 |
|
| 2015 |
Shin MC, Zhao J, Zhang J, Huang Y, He H, Wang M, Min KA, Yang VC. Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction. Journal of Biomedical Materials Research. Part A. 103: 409-19. PMID 24733757 DOI: 10.1002/Jbm.A.35188 |
0.417 |
|
| 2014 |
Liu E, Sheng J, Ye J, Wang Y, Gong J, Yang VC, Wang J, He H. CPP mediated insulin delivery: current status and promising future. Current Pharmaceutical Biotechnology. 15: 240-55. PMID 25312540 DOI: 10.2174/1389201015666140813125840 |
0.316 |
|
| 2014 |
Shin MC, Zhang J, Min KA, Lee K, Moon C, Balthasar JP, Yang VC. Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. 194: 197-210. PMID 25204286 DOI: 10.1016/J.Jconrel.2014.08.030 |
0.596 |
|
| 2014 |
Wang H, Zhao Y, Wang H, Gong J, He H, Shin MC, Yang VC, Huang Y. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer. Journal of Controlled Release : Official Journal of the Controlled Release Society. 192: 47-56. PMID 25003794 DOI: 10.1016/J.Jconrel.2014.06.051 |
0.406 |
|
| 2014 |
He H, Ye J, Liu E, Liang Q, Liu Q, Yang VC. Low molecular weight protamine (LMWP): a nontoxic protamine substitute and an effective cell-penetrating peptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 193: 63-73. PMID 24943246 DOI: 10.1016/J.Jconrel.2014.05.056 |
0.36 |
|
| 2014 |
He H, Ye J, Wang Y, Liu Q, Chung HS, Kwon YM, Shin MC, Lee K, Yang VC. Cell-penetrating peptides meditated encapsulation of protein therapeutics into intact red blood cells and its application. Journal of Controlled Release : Official Journal of the Controlled Release Society. 176: 123-32. PMID 24374002 DOI: 10.1016/J.Jconrel.2013.12.019 |
0.396 |
|
| 2014 |
Zhang J, Shin MC, Yang VC. Magnetic targeting of novel heparinized iron oxide nanoparticles evaluated in a 9L-glioma mouse model. Pharmaceutical Research. 31: 579-92. PMID 24065589 DOI: 10.1007/S11095-013-1182-5 |
0.364 |
|
| 2014 |
Absar S, Nahar K, Choi S, Ahsan F, Yang VC, Kwon YM. Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules. Journal of Biomedical Materials Research. Part A. 102: 2481-90. PMID 23946132 DOI: 10.1002/Jbm.A.34916 |
0.436 |
|
| 2014 |
Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC. Cell-penetrating peptides: achievements and challenges in application for cancer treatment. Journal of Biomedical Materials Research. Part A. 102: 575-87. PMID 23852939 DOI: 10.1002/Jbm.A.34859 |
0.441 |
|
| 2014 |
Ren X, Chen H, Yang V, Sun D. Iron oxide nanoparticle-based theranostics for cancer imaging and therapy Frontiers of Chemical Science and Engineering. 8: 253-264. DOI: 10.1007/S11705-014-1425-Y |
0.321 |
|
| 2014 |
Wang Y, Jiang Y, Zhang M, Tan J, Liang J, Wang H, Li Y, He H, Yang VC, Huang Y. Protease-Activatable Hybrid Nanoprobe for Tumor Imaging Advanced Functional Materials. 24: 5443-5453. DOI: 10.1002/Adfm.201400419 |
0.361 |
|
| 2013 |
Zhang J, Shin MC, David AE, Zhou J, Lee K, He H, Yang VC. Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. Molecular Pharmaceutics. 10: 3892-902. PMID 24024964 DOI: 10.1021/Mp400360Q |
0.417 |
|
| 2013 |
Zhou J, Zhang J, David AE, Yang VC. Magnetic tumor targeting of β-glucosidase immobilized iron oxide nanoparticles. Nanotechnology. 24: 375102. PMID 23974977 DOI: 10.1088/0957-4484/24/37/375102 |
0.355 |
|
| 2013 |
Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min KA, Kim JH, Yang VC. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 169-78. PMID 23973813 DOI: 10.1016/J.Jconrel.2013.08.016 |
0.409 |
|
| 2013 |
Min KA, Shin MC, Yu F, Yang M, David AE, Yang VC, Rosania GR. Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers Acs Nano. 7: 2161-2171. PMID 23373613 DOI: 10.1021/Nn3057565 |
0.329 |
|
| 2013 |
Huang Y, Jiang Y, Wang H, Wang J, Shin MC, Byun Y, He H, Liang Y, Yang VC. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Advanced Drug Delivery Reviews. 65: 1299-315. PMID 23369828 DOI: 10.1016/J.Addr.2012.11.007 |
0.422 |
|
| 2013 |
He H, David A, Chertok B, Cole A, Lee K, Zhang J, Wang J, Huang Y, Yang VC. Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system. Pharmaceutical Research. 30: 2445-58. PMID 23344909 DOI: 10.1007/S11095-013-0982-Y |
0.776 |
|
| 2013 |
Absar S, Choi S, Ahsan F, Cobos E, Yang VC, Kwon YM. Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis. Thrombosis Research. 131: e91-9. PMID 23269380 DOI: 10.1016/J.Thromres.2012.11.030 |
0.353 |
|
| 2013 |
Park YS, David AE, Park KM, Lin CY, Than KD, Lee K, Park JB, Jo I, Park KD, Yang VC. Controlled release of simvastatin from in situ forming hydrogel triggers bone formation in MC3T3-E1 cells. The Aaps Journal. 15: 367-76. PMID 23250670 DOI: 10.1208/S12248-012-9442-6 |
0.325 |
|
| 2013 |
Sun Y, Dong W, Wang H, Huang Y, Gu H, Yang VC, Gong J. Template synthesis of PMAA@chitosan hollow nanorods for docetaxel delivery Polymer Chemistry. 4: 2489-2495. DOI: 10.1039/C3Py21157F |
0.421 |
|
| 2013 |
He H, Liang Q, Shin MC, Lee K, Gong J, Ye J, Liu Q, Wang J, Yang V. Significance and strategies in developing delivery systems for bio-macromolecular drugs Frontiers of Chemical Science and Engineering. 7: 496-507. DOI: 10.1007/S11705-013-1362-1 |
0.348 |
|
| 2013 |
Ye J, He H, Gong J, Dong W, Huang Y, Wang J, Chen G, Yang VC. Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy Frontiers of Chemical Science and Engineering. 7: 20-28. DOI: 10.1007/S11705-013-1311-Z |
0.394 |
|
| 2013 |
He H, Ye J, Sheng J, Wang J, Huang Y, Chen G, Wang J, Yang VC. Overcoming oral insulin delivery barriers: application of cell penetrating peptide and silica-based nanoporous composites Frontiers of Chemical Science and Engineering. 7: 9-19. DOI: 10.1007/S11705-013-1306-9 |
0.323 |
|
| 2012 |
Adulnirath A, Chung SW, Park J, Hwang SR, Kim JY, Yang VC, Kim SY, Moon HT, Byun Y. Cyclic RGDyk-conjugated LMWH-taurocholate derivative as a targeting angiogenesis inhibitor. Journal of Controlled Release : Official Journal of the Controlled Release Society. 164: 8-16. PMID 23063549 DOI: 10.1016/J.Jconrel.2012.10.001 |
0.351 |
|
| 2012 |
Hwang SR, Seo DH, Al-Hilal TA, Jeon OC, Kang JH, Kim SH, Kim HS, Chang YT, Kang YM, Yang VC, Byun Y. Orally active desulfated low molecular weight heparin and deoxycholic acid conjugate, 6ODS-LHbD, suppresses neovascularization and bone destruction in arthritis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 374-84. PMID 23041275 DOI: 10.1016/J.Jconrel.2012.09.013 |
0.311 |
|
| 2012 |
Wang J, Huang Y, David AE, Chertok B, Zhang L, Yu F, Yang VC. Magnetic nanoparticles for MRI of brain tumors. Current Pharmaceutical Biotechnology. 13: 2403-16. PMID 23016645 DOI: 10.2174/138920112803341824 |
0.694 |
|
| 2012 |
Zhang J, Deng D, Zhu H, Byun Y, Yang VC, Gu Y. Folate-conjugated thermo-responsive micelles for tumor targeting. Journal of Biomedical Materials Research. Part A. 100: 3134-42. PMID 22826176 DOI: 10.1002/Jbm.A.34230 |
0.394 |
|
| 2012 |
Shen M, Huang Y, Han L, Qin J, Fang X, Wang J, Yang VC. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. Journal of Controlled Release : Official Journal of the Controlled Release Society. 161: 884-92. PMID 22587941 DOI: 10.1016/J.Jconrel.2012.05.013 |
0.442 |
|
| 2012 |
Kim JY, Shim G, Choi HW, Park J, Chung SW, Kim S, Kim K, Kwon IC, Kim CW, Kim SY, Yang VC, Oh YK, Byun Y. Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex. Biomaterials. 33: 4424-30. PMID 22425551 DOI: 10.1016/J.Biomaterials.2012.02.066 |
0.412 |
|
| 2012 |
Lee TY, Park YS, Garcia GA, Sunahara RK, Woods JH, Yang VC. Cell permeable cocaine esterases constructed by chemical conjugation and genetic recombination. Molecular Pharmaceutics. 9: 1361-73. PMID 22404344 DOI: 10.1021/Mp200623W |
0.556 |
|
| 2012 |
David AE, Gong J, Chertok B, Domszy RC, Moon C, Park YS, Wang NS, Yang AJ, Yang VC. Immobilized thermolysin for highly efficient production of low-molecular-weight protamine--an attractive cell-penetrating peptide for macromolecular drug delivery applications. Journal of Biomedical Materials Research. Part A. 100: 211-9. PMID 22042599 DOI: 10.1002/Jbm.A.33244 |
0.749 |
|
| 2012 |
Absar S, Choi S, Yang VC, Kwon YM. Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 157: 46-54. PMID 21930168 DOI: 10.1016/J.Jconrel.2011.09.060 |
0.359 |
|
| 2011 |
David AE, Cole AJ, Yang VC. Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold? Nanomedicine (London, England). 6: 1133-5. PMID 21929450 DOI: 10.2217/Nnm.11.99 |
0.572 |
|
| 2011 |
Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 393-9. PMID 21763736 DOI: 10.1016/J.Jconrel.2011.06.033 |
0.704 |
|
| 2011 |
Cole AJ, David AE, Wang J, Galbán CJ, Yang VC. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials. 32: 6291-301. PMID 21684593 DOI: 10.1016/J.Biomaterials.2011.05.024 |
0.615 |
|
| 2011 |
Chertok B, David AE, Yang VC. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. Biomaterials. 32: 6245-53. PMID 21632104 DOI: 10.1016/J.Biomaterials.2011.05.004 |
0.716 |
|
| 2011 |
Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends in Biotechnology. 29: 323-32. PMID 21489647 DOI: 10.1016/J.Tibtech.2011.03.001 |
0.58 |
|
| 2011 |
Li J, Feng L, Fan L, Zha Y, Guo L, Zhang Q, Chen J, Pang Z, Wang Y, Jiang X, Yang VC, Wen L. Targeting the brain with PEG-PLGA nanoparticles modified with phage-displayed peptides. Biomaterials. 32: 4943-50. PMID 21470674 DOI: 10.1016/J.Biomaterials.2011.03.031 |
0.404 |
|
| 2011 |
Choi YS, Lee JY, Suh JS, Lee SJ, Yang VC, Chung CP, Park YJ. Cell penetrating peptides for tumor targeting. Current Pharmaceutical Biotechnology. 12: 1166-82. PMID 21470141 DOI: 10.2174/138920111796117391 |
0.424 |
|
| 2011 |
David AE, Cole AJ, Chertok B, Park YS, Yang VC. A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 152: 67-75. PMID 21295085 DOI: 10.1016/J.Jconrel.2011.01.033 |
0.73 |
|
| 2011 |
Huang Y, Rao Y, Chen J, Yang VC, Liang W. Polysorbate cationic synthetic vesicle for gene delivery. Journal of Biomedical Materials Research. Part A. 96: 513-9. PMID 21254382 DOI: 10.1002/Jbm.A.32999 |
0.312 |
|
| 2011 |
Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 32: 2183-93. PMID 21176955 DOI: 10.1016/J.Biomaterials.2010.11.040 |
0.572 |
|
| 2011 |
Lee JY, Choi YS, Suh JS, Kwon YM, Yang VC, Lee SJ, Chung CP, Park YJ. Cell-penetrating chitosan/doxorubicin/TAT conjugates for efficient cancer therapy. International Journal of Cancer. 128: 2470-80. PMID 20669230 DOI: 10.1002/Ijc.25578 |
0.402 |
|
| 2010 |
Min KA, Yu F, Yang VC, Zhang X, Rosania GR. Transcellular Transport of Heparin-coated Magnetic Iron Oxide Nanoparticles (Hep-MION) Under the Influence of an Applied Magnetic Field. Pharmaceutics. 2: 119-135. PMID 21152371 DOI: 10.3390/Pharmaceutics2020119 |
0.354 |
|
| 2010 |
Park JW, Jeon OC, Kim SK, Al-Hilal TA, Jin SJ, Moon HT, Yang VC, Kim SY, Byun Y. High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives. Journal of Controlled Release : Official Journal of the Controlled Release Society. 148: 317-26. PMID 20869408 DOI: 10.1016/J.Jconrel.2010.09.014 |
0.396 |
|
| 2010 |
Huang Y, Yu F, Park YS, Wang J, Shin MC, Chung HS, Yang VC. Co-administration of protein drugs with gold nanoparticles to enable percutaneous delivery. Biomaterials. 31: 9086-91. PMID 20828812 DOI: 10.1016/J.Biomaterials.2010.08.046 |
0.336 |
|
| 2010 |
Huang Y, Park YS, Wang J, Moon C, Kwon YM, Chung HS, Park YJ, Yang VC. ATTEMPTS system: a macromolecular prodrug strategy for cancer drug delivery. Current Pharmaceutical Design. 16: 2369-76. PMID 20618157 DOI: 10.2174/138161210791920441 |
0.658 |
|
| 2010 |
Chertok B, David AE, Yang VC. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials. 31: 6317-24. PMID 20494439 DOI: 10.1016/J.Biomaterials.2010.04.043 |
0.722 |
|
| 2010 |
Yu F, Zhang L, Huang Y, Sun K, David AE, Yang VC. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials. 31: 5842-8. PMID 20434209 DOI: 10.1016/J.Biomaterials.2010.03.072 |
0.394 |
|
| 2010 |
Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Synthetic skin-permeable proteins enabling needleless immunization. Angewandte Chemie (International Ed. in English). 49: 2724-7. PMID 20232417 DOI: 10.1002/Anie.200906153 |
0.596 |
|
| 2010 |
Park YS, Huang Y, Park YJ, David AE, White L, He H, Chung HS, Yang VC. Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 144: 82-90. PMID 20109509 DOI: 10.1016/J.Jconrel.2010.01.026 |
0.311 |
|
| 2010 |
Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Molecular Pharmaceutics. 7: 375-85. PMID 20039679 DOI: 10.1021/Mp900161H |
0.734 |
|
| 2010 |
Choi YS, Lee JY, Suh JS, Kwon YM, Lee SJ, Chung JK, Lee DS, Yang VC, Chung CP, Park YJ. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials. 31: 1429-43. PMID 19954842 DOI: 10.1016/J.Biomaterials.2009.11.001 |
0.385 |
|
| 2010 |
Park JB, Kwon YM, Lee TY, Brim R, Ko MC, Sunahara RK, Woods JH, Yang VC. PEGylation of bacterial cocaine esterase for protection against protease digestion and immunogenicity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 174-9. PMID 19857534 DOI: 10.1016/J.Jconrel.2009.10.015 |
0.544 |
|
| 2010 |
Urva SR, Yang VC, Balthasar JP. Physiologically based pharmacokinetic model for T84.66: a monoclonal anti-CEA antibody. Journal of Pharmaceutical Sciences. 99: 1582-600. PMID 19774657 DOI: 10.1002/Jps.21918 |
0.322 |
|
| 2010 |
Yu F, Yang VC. Size-tunable synthesis of stable superparamagnetic iron oxide nanoparticles for potential biomedical applications. Journal of Biomedical Materials Research. Part A. 92: 1468-75. PMID 19402138 DOI: 10.1002/Jbm.A.32489 |
0.307 |
|
| 2010 |
He H, Dong W, Gong J, Wang J, Yang VC. Developing macromolecular therapeutics: The future drug-of-choice Frontiers of Chemical Engineering in China. 4: 10-17. DOI: 10.1007/S11705-009-0291-5 |
0.364 |
|
| 2009 |
Chen JS, Chan DC, Chung MJ, Chang LC, Yang VC. Altered fibrinolytic activities in gastric cancer and uremic patients after intervention. Clinical Nephrology. 72: 468-72. PMID 19954724 |
0.444 |
|
| 2009 |
Zhang H, Wang L, Park JB, Park P, Yang VC, Hollister SJ, La Marca F, Lin CY. Intradiscal injection of simvastatin retards progression of intervertebral disc degeneration induced by stab injury. Arthritis Research & Therapy. 11: R172. PMID 19912653 DOI: 10.1186/Ar2861 |
0.312 |
|
| 2009 |
Zhang L, Yu F, Cole AJ, Chertok B, David AE, Wang J, Yang VC. Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. The Aaps Journal. 11: 693-9. PMID 19842043 DOI: 10.1208/S12248-009-9151-Y |
0.746 |
|
| 2009 |
Chertok B, David AE, Moffat BA, Yang VC. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials. 30: 6780-7. PMID 19782394 DOI: 10.1016/J.Biomaterials.2009.08.040 |
0.721 |
|
| 2009 |
Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). Journal of Controlled Release : Official Journal of the Controlled Release Society. 139: 182-9. PMID 19577600 DOI: 10.1016/J.Jconrel.2009.06.027 |
0.592 |
|
| 2009 |
Yu F, Huang Y, Cole AJ, Yang VC. The artificial peroxidase activity of magnetic iron oxide nanoparticles and its application to glucose detection. Biomaterials. 30: 4716-22. PMID 19515418 DOI: 10.1016/J.Biomaterials.2009.05.005 |
0.548 |
|
| 2009 |
Li YT, Kwon YM, Spangrude GJ, Liang JF, Chung HS, Park YJ, Yang VC. Preliminary in vivo evaluation of the protein transduction domain-modified ATTEMPTS approach in enhancing asparaginase therapy. Journal of Biomedical Materials Research. Part A. 91: 209-20. PMID 18814276 DOI: 10.1002/Jbm.A.32204 |
0.542 |
|
| 2008 |
Suh JS, Lee JY, Choi YS, Yu F, Yang V, Lee SJ, Chung CP, Park YJ. Efficient labeling of mesenchymal stem cells using cell permeable magnetic nanoparticles. Biochemical and Biophysical Research Communications. 379: 669-75. PMID 19101509 DOI: 10.1016/J.Bbrc.2008.12.041 |
0.353 |
|
| 2008 |
Kwon YM, Li Y, Naik S, Liang JF, Huang Y, Park YJ, Yang VC. The ATTEMPTS delivery systems for macromolecular drugs. Expert Opinion On Drug Delivery. 5: 1255-66. PMID 18976135 DOI: 10.1517/17425240802498059 |
0.693 |
|
| 2008 |
Kwon YM, Li YT, Liang JF, Park YJ, Chang LC, Yang VC. PTD-modified ATTEMPTS system for enhanced asparaginase therapy: a proof-of-concept investigation. Journal of Controlled Release : Official Journal of the Controlled Release Society. 130: 252-8. PMID 18652856 DOI: 10.1016/J.Jconrel.2008.06.017 |
0.692 |
|
| 2008 |
Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 29: 487-96. PMID 17964647 DOI: 10.1016/J.Biomaterials.2007.08.050 |
0.708 |
|
| 2008 |
Moon C, Kwon YM, Lee WK, Park YJ, Chang LC, Yang VC. A novel polyrotaxane-based intracellular delivery system for camptothecin: in vitro feasibility evaluation. Journal of Biomedical Materials Research. Part A. 84: 238-46. PMID 17607767 DOI: 10.1002/Jbm.A.31452 |
0.72 |
|
| 2008 |
Chertok B, David A, Yang V. Delivery of functional proteins to brain tumor using MRI-monitored, magnetically-targeted nanoparticles Journal of Controlled Release. 132: e61-e62. DOI: 10.1016/J.Jconrel.2008.09.058 |
0.708 |
|
| 2008 |
Chertok B, David AE, Yang VC. Glioma-targeted platform for potential intracellular drug delivery: Design and evaluation 8th World Biomaterials Congress 2008. 2: 951. |
0.654 |
|
| 2008 |
Chertok B, David AE, Yang VC. Strategies for enhanced brain tumor accumulation of magnetic nanoparticles for potential drug delivery Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 8-11. |
0.682 |
|
| 2007 |
Moon C, Kwon YM, Lee WK, Park YJ, Yang VC. In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. Journal of Controlled Release : Official Journal of the Controlled Release Society. 124: 43-50. PMID 17904680 DOI: 10.1016/J.Jconrel.2007.08.029 |
0.642 |
|
| 2007 |
Chertok B, David AE, Huang Y, Yang VC. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 122: 315-23. PMID 17628157 DOI: 10.1016/J.Jconrel.2007.05.030 |
0.702 |
|
| 2005 |
Yang VC, Naik SS, Song H, Dombkowski AA, Crippen G, Liang JF. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 110: 164-76. PMID 16260060 DOI: 10.1016/J.Jconrel.2005.09.027 |
0.575 |
|
| 2005 |
Wang T, Yang Z, Emregul E, David A, Balthasar JP, Liang J, Yang VC. Strategies for improving the functionality of an affinity bioreactor. International Journal of Pharmaceutics. 306: 132-41. PMID 16246511 DOI: 10.1016/J.Ijpharm.2005.09.011 |
0.612 |
|
| 2005 |
Liang JF, Yang VC. Synthesis of doxorubicin-peptide conjugate with multidrug resistant tumor cell killing activity. Bioorganic & Medicinal Chemistry Letters. 15: 5071-5. PMID 16168650 DOI: 10.1016/J.Bmcl.2005.07.087 |
0.363 |
|
| 2005 |
Park YJ, Chang LC, Liang JF, Moon C, Chung CP, Yang VC. Nontoxic membrane translocation peptide from protamine, low molecular weight protamine (LMWP), for enhanced intracellular protein delivery: in vitro and in vivo study. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1555-7. PMID 16033808 DOI: 10.1096/Fj.04-2322Fje |
0.715 |
|
| 2005 |
Chang LC, Lee HF, Chung MJ, Yang VC. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation. Bioconjugate Chemistry. 16: 147-55. PMID 15656586 DOI: 10.1021/Bc0499735 |
0.554 |
|
| 2005 |
Naik SS, Liang JF, Park YJ, Lee WK, Yang VC. Application of "ATTEMPTS" for drug delivery. Journal of Controlled Release : Official Journal of the Controlled Release Society. 101: 35-45. PMID 15588892 DOI: 10.1016/J.Jconrel.2004.07.020 |
0.61 |
|
| 2004 |
Chen PC, Kohane DS, Park YJ, Bartlett RH, Langer R, Yang VC. Injectable microparticle-gel system for prolonged and localized lidocaine release. II. In vivo anesthetic effects. Journal of Biomedical Materials Research. Part A. 70: 459-66. PMID 15293320 DOI: 10.1002/Jbm.A.30101 |
0.682 |
|
| 2004 |
Chen PC, Park YJ, Chang LC, Kohane DS, Bartlett RH, Langer R, Yang VC. Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization. Journal of Biomedical Materials Research. Part A. 70: 412-9. PMID 15293314 DOI: 10.1002/Jbm.A.30086 |
0.739 |
|
| 2003 |
Park YJ, Liang JF, Ko KS, Kim SW, Yang VC. Low molecular weight protamine as an efficient and nontoxic gene carrier: in vitro study. The Journal of Gene Medicine. 5: 700-11. PMID 12898639 DOI: 10.1002/Jgm.402 |
0.315 |
|
| 2003 |
Liang JF, Zhen L, Chang LC, Yang VC. A less toxic heparin antagonist--low molecular weight protamine. Biochemistry. Biokhimii︠a︡. 68: 116-20. PMID 12693985 DOI: 10.1023/A:1022109905487 |
0.524 |
|
| 2003 |
Park YJ, Liang JF, Song H, Li YT, Naik S, Yang VC. ATTEMPTS: a heparin/protamine-based triggered release system for the delivery of enzyme drugs without associated side-effects. Advanced Drug Delivery Reviews. 55: 251-65. PMID 12564979 DOI: 10.1016/S0169-409X(02)00181-3 |
0.675 |
|
| 2002 |
Yang Z, Zhang Y, Markland P, Yang VC. Poly(glutamic acid) poly(ethylene glycol) hydrogels prepared by photoinduced polymerization: Synthesis, characterization, and preliminary release studies of protein drugs. Journal of Biomedical Materials Research. 62: 14-21. PMID 12124782 DOI: 10.1002/Jbm.10219 |
0.355 |
|
| 2002 |
Liang JF, Li YT, Song H, Park YJ, Naik SS, Yang VC. ATTEMPTS: a heparin/protamine-based delivery system for enzyme drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 78: 67-79. PMID 11772450 DOI: 10.1016/S0168-3659(01)00484-9 |
0.644 |
|
| 2001 |
Lee LM, Chang LC, Wrobleski S, Wakefield TW, Yang VC. Low molecular weight protamine as nontoxic heparin/low molecular weight heparin antidote (III): preliminary in vivo evaluation of efficacy and toxicity using a canine model. Aaps Pharmsci. 3: E19. PMID 11741270 DOI: 10.1208/Ps030319 |
0.678 |
|
| 2001 |
Chang LC, Liang JF, Lee HF, Lee LM, Yang VC. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (II): in vitro evaluation of efficacy and toxicity. Aaps Pharmsci. 3: E18. PMID 11741269 DOI: 10.1208/Ps030318 |
0.664 |
|
| 2001 |
Chang LC, Lee HF, Yang Z, Yang VC. Low molecular weight protamine (LMWP) as nontoxic heparin/low molecular weight heparin antidote (I): preparation and characterization. Aaps Pharmsci. 3: E17. PMID 11741268 DOI: 10.1208/Ps030317 |
0.561 |
|
| 2001 |
Park YJ, Liang J, Yang Z, Yang VC. Controlled release of clot-dissolving tissue-type plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel Journal of Controlled Release. 75: 37-44. PMID 11451495 DOI: 10.1016/S0168-3659(01)00360-1 |
0.315 |
|
| 2001 |
Liang JF, Park YJ, Song H, Li YT, Yang VC. ATTEMPTS: a heparin/protamine-based prodrug approach for delivery of thrombolytic drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 72: 145-56. PMID 11389993 DOI: 10.1016/S0168-3659(01)00270-X |
0.483 |
|
| 2000 |
Liang JF, Li YT, Connell ME, Yang VC. Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system. Aaps Pharmsci. 2: E7. PMID 11741223 DOI: 10.1208/ps020107 |
0.464 |
|
| 2000 |
Song H, Liang JF, Yang VC. A prodrug approach for delivery of t-PA: Construction of the cationic t-PA prodrug by a recombinant method and preliminary in vitro evaluation of the construct Asaio Journal. 46: 663-668. PMID 11110262 DOI: 10.1097/00002480-200011000-00005 |
0.359 |
|
| 2000 |
Byun Y, Chang LC, Lee LM, Han IS, Singh VK, Yang VC. Low molecular weight protamine: a potent but nontoxic antagonist to heparin/low molecular weight protamine. Asaio Journal (American Society For Artificial Internal Organs : 1992). 46: 435-9. PMID 10926141 DOI: 10.1097/00002480-200007000-00013 |
0.663 |
|
| 2000 |
Liang JF, Li YT, Yang VC. A novel approach for delivery of enzyme drugs: preliminary demonstration of feasibility and utility in vitro. International Journal of Pharmaceutics. 202: 11-20. PMID 10915922 DOI: 10.1016/S0378-5173(00)00414-2 |
0.475 |
|
| 2000 |
Liang JF, Li YT, Yang VC. Biomedical application of immobilized enzymes. Journal of Pharmaceutical Sciences. 89: 979-90. PMID 10906721 DOI: 10.1002/1520-6017(200008)89:8<979::AID-JPS2>3.0.CO;2-H |
0.364 |
|
| 2000 |
Liang JF, Song H, Li YT, Yang VC. A novel heparin/protamine-based pro-drug type delivery system for protease drugs. Journal of Pharmaceutical Sciences. 89: 664-73. PMID 10756332 DOI: 10.1002/(SICI)1520-6017(200005)89:5<664::AID-JPS12>3.0.CO;2-9 |
0.495 |
|
| 2000 |
Liang JF, Li Y, Yang VC. The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activation. Thrombosis Research. 97: 349-58. PMID 10709911 DOI: 10.1016/S0049-3848(99)00188-7 |
0.455 |
|
| 1999 |
Chang LC, Meyerhoff ME, Yang VC. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection. Analytical Biochemistry. 276: 8-12. PMID 10585738 DOI: 10.1006/Abio.1999.4299 |
0.488 |
|
| 1999 |
Markland P, Zhang Y, Amidon GL, Yang VC. A pH- and ionic strength-responsive polypeptide hydrogel: Synthesis, characterization, and preliminary protein release studies Journal of Biomedical Materials Research. 47: 595-602. PMID 10497296 DOI: 10.1002/(Sici)1097-4636(19991215)47:4<595::Aid-Jbm17>3.0.Co;2-I |
0.304 |
|
| 1999 |
Yun JH, Han IS, Chang LC, Ramamurthy N, Meyerhoff ME, Yang VC. Electrochemical sensors for polyionic macromolecules: development and applications in pharmaceutical research. Pharmaceutical Science & Technology Today. 2: 102-110. PMID 10322363 DOI: 10.1016/S1461-5347(99)00121-2 |
0.478 |
|
| 1999 |
Byun Y, Singh VK, Yang VC. Low molecular weight protamine: A potential nontoxic heparin antagonist Thrombosis Research. 94: 53-61. PMID 10213181 DOI: 10.1016/S0049-3848(98)00201-1 |
0.357 |
|
| 1999 |
Wang H, Song H, Yang VC. A recombinant prodrug type approach for triggered delivery of streptokinase Journal of Controlled Release. 59: 119-122. PMID 10210728 DOI: 10.1016/S0168-3659(99)00019-X |
0.341 |
|
| 1999 |
Markland P, Amidon GL, Yang VC. Modified polypeptides containing γ-benzyl glutamic acid as drug delivery platforms International Journal of Pharmaceutics. 178: 183-192. PMID 10205638 DOI: 10.1016/S0378-5173(98)00373-1 |
0.328 |
|
| 1999 |
Yang VC, Lee TY, Hwang GY, Kao CH, Chen JK. Immunolocalization of high-density lipoproteins in arterial walls of rats. Atherosclerosis. 142: 269-77. PMID 10030377 DOI: 10.1016/S0021-9150(98)00238-X |
0.456 |
|
| 1996 |
Byun Y, Wang T, Kim JS, Yang VC. Optimization and assessment of the in vivo efficacy of a heparin removing bio-reactor using mathematical modeling. Asaio Journal (American Society For Artificial Internal Organs : 1992). 42: M782-7. PMID 8944989 DOI: 10.1097/00002480-199609000-00096 |
0.571 |
|
| 1996 |
Guo X, Han IS, Yang VC, Meyerhoff ME. Homogeneous enzyme-based binding assay for studying glycosaminoglycan interactions with macromolecules and peptides. Analytical Biochemistry. 235: 153-60. PMID 8833323 DOI: 10.1006/Abio.1996.0107 |
0.304 |
|
| 1996 |
Wahr JA, Yun JH, Yang VC, Lee LM, Fu B, Meyerhoff ME. A new method of measuring heparin levels in whole blood by protamine titration using a heparin-responsive electrochemical sensor. Journal of Cardiothoracic and Vascular Anesthesia. 10: 447-50. PMID 8776635 DOI: 10.1016/S1053-0770(05)80002-3 |
0.488 |
|
| 1995 |
Yun JH, Lee LM, Wahr JA, Fu B, Meyerhoff ME, Yang VC. Clinical application of disposable heparin sensors. Blood heparin measurements during open heart surgery. Asaio Journal (American Society For Artificial Internal Organs : 1992). 41: M661-4. PMID 8573887 DOI: 10.1097/00002480-199507000-00093 |
0.441 |
|
| 1988 |
Bernstein J, Yang VC, Cooney CL, Langer R. Immobilized heparin lyase system for blood deheparinization Methods in Enzymology. 137: 515-529. PMID 3374357 DOI: 10.1016/0076-6879(88)37048-5 |
0.392 |
|
| 1986 |
Yang VC, Bernstein H, Cooney CL, Kadam JC, Langer R. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase Thrombosis Research. 44: 599-610. PMID 3810562 DOI: 10.1016/0049-3848(86)90162-3 |
0.399 |
|
| 1985 |
Yang VC, Morgan L, McCarty MT, Langer R. Isoelectric points of the polysaccharide-degrading enzymes in Flavobacterium heparinum Carbohydrate Research. 143: 294-299. PMID 4084918 DOI: 10.1016/S0008-6215(00)90723-7 |
0.347 |
|
| 1985 |
Yang VC, Turcotte JG, Steim JM. Biophysical properties of cytidine diphosphate diacylglycerol in solution. Biochimica Et Biophysica Acta. 834: 364-75. PMID 3995072 DOI: 10.1016/0005-2760(85)90010-4 |
0.645 |
|
| 1982 |
Yang VC, Turcotte JG, Steim JM. Physical properties of arabinofuranosylcytosine diphosphate diacylglycerol, an antitumor liponucleotide. Biochimica Et Biophysica Acta. 689: 375-84. PMID 7115716 DOI: 10.1016/0005-2736(82)90272-3 |
0.64 |
|
| Show low-probability matches. |
